PHARMAZZ
Pharmazz they are focused on discovering, acquiring, developing, and commercializing therapeutics for care medicine.
PHARMAZZ
Industry:
Biotechnology Health Care Medical Pharmaceutical Service Industry
Founded:
2010-01-01
Address:
Willowbrook, Illinois, United States
Country:
United States
Website Url:
http://www.pharmazz.com
Total Employee:
11+
Status:
Active
Contact:
+1 (630)780-6087
Email Addresses:
[email protected]
Total Funding:
5.82 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Font Awesome Google Maps COVID-19 Japanese Yen
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.pharmazz.com
- Host name: 209.8.63.50.host.secureserver.net
- IP address: 50.63.8.209
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Pharmazz"
Pharmazz - Wikipedia
Pharmazz Inc. is an American biopharmaceutical company headquartered in Willowbrook, Illinois. Its work focusses on clinical trials related to hypovolaemic shock and stroke, with drugs targeting adrenoceptors and endothlin receptors. See details»
Overview | Pharmazz, Inc.
Pharmazz, Inc. was incorporated in 2010 and is a Delaware corporation based in Willowbrook, Illinois. Download Introduction to Pharmazz. Quick Contact. [email protected]; Pharmazz, …See details»
Pharmazz - Crunchbase Company Profile & Funding
When was the last funding round for Pharmazz? Pharmazz closed its last funding round on Aug 15, 2024 from a Corporate Round round. Who are Pharmazz 's competitors? Alternatives and …See details»
Pharmazz, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Pharmazz, Inc. obtained marketing authorization for two of its first-in-class drug molecules, Centhaquine and Sovateltide, for hypovolemic shock and ischemic stroke, respectively, in …See details»
Pharmazz Inc. | LinkedIn
Pharmazz Inc. | 1,853 followers on LinkedIn. Saving Lives Through Innovation | Pharmazz is a privately held company developing novel products in critical care medicine. The U.S. Food and …See details»
Pharmazz Company Profile 2024: Valuation, Funding & Investors
When was Pharmazz founded? Pharmazz was founded in 2010. Where is Pharmazz headquartered? Pharmazz is headquartered in Willowbrook, IL. What is the size of Pharmazz? …See details»
Pharmazz Inc. and Sun Pharma entered into an agreement under …
Aug 21, 2024 Strategic equity investment of $15 M to support completion of Pharmazz's pivotal Phase 3 study for Sovateltide to treat patients with acute cerebral ischemic strokeExpansion of …See details»
Pharmazz, Inc has two products in late-stage clinical trials
Pharmazz, Inc. Pharmazz, Inc. is an innovative biopharmaceutical company with an approved product, promising drug pipeline and a seasoned management team. It is a Delaware …See details»
Pharmazz Inc. announces that Dr. Neil Marwah has joined the …
Sep 11, 2024 Pharmazz, Inc. Four presentations will be made at the 16th World Stroke Congress in Abu Dhabi on 23-26 October 2024. WILLOWBROOK, Ill., Sept. 11, 2024 (GLOBE …See details»
History | Pharmazz, Inc.
History. Established in 2010, Pharmazz, Inc. is an emerging global pharmaceutical company. Focus of the company is to discover, acquire, develop, and market novel pharmaceutical …See details»
Pharmazz Inc. and Sun Pharma enter into licensing agreement for ...
Sep 14, 2023 Pharmazz, Inc. Sovateltide is a first of its kind drug to treat acute cerebral ischemic stroke that can be administered up to 24 hours after the onset of symptomsSee details»
Pharmazz Inc. Announces Positive Results of Phase III ... - BioSpace
May 25, 2022 Pharmazz, Inc. (“Pharmazz”), ... The results have prompted Pharmazz to apply for marketing authorization from the Indian Central Drugs Standard Control Organization …See details»
Pharmazz Inc. Announces Positive Results of Phase III
May 25, 2022 The results have prompted Pharmazz to apply for marketing authorization from the Indian Central Drugs Standard Control Organization (CDSCO). In addition, the full data set …See details»
Pharmazz Inc. Announces Completion of Enrollment of Phase
Feb 17, 2022 About Pharmazz, Inc. Pharmazz, Inc. is a privately held company engaged in developing novel products in critical care medicine. Additional information may be found on the …See details»
Corporate Presentation - Pharmazz
Pharmazz believes that the industry data is accurate and that the estimates and assumptions are reasonable, but there is no assurance as to the accuracy or completeness of this data. …See details»
Pharmazz Inc. Presents Data From its Positive Phase III
Sep 13, 2022 The study has shown the safety and efficacy of centhaquine as an adjuvant to standard of care (SOC) in the treatment of hypovolemic shock. September 13, 2022 07:00 ET …See details»
Press Releases | Pharmazz, Inc.
WILLOWBROOK, Ill., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Pharmazz, Inc. (“Pharmazz”), a biopharmaceutical company focused on developing and commercializing novel therapeutics to …See details»
Pharmazz Inc. Announces Positive Results of Phase III Clinical Trial ...
May 25, 2022 The results have prompted Pharmazz to apply for marketing authorization from the Indian Central Drugs Standard Control Organization (CDSCO). In addition, the full data set …See details»
Pharmazz Inc. submits Investigational New Drug Application
Feb 3, 2022 Pharmazz Inc. submits Investigational New Drug Application to India Central Drugs Standard Control Organization for a Phase II clinical trial of sovateltide (PMZ-1620) in hypoxic …See details»